ICD-10-PCS › X New Technology › XW Anatomical Regions › XW1 New Technology, Anatomical... › XW143F8
XW143F8
Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
ValidICD-10-PCS procedure code.
Valid for claims with a date of service in the current code year.
What has happened to this code
Every change the publisher made, from 2023 to now.
- FY2023 Added to the code set Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8
-
FY2027
Description revised
Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
What this code says
Each character is read in its own position, so the same letter means different things in different places. Definitions are CMS's own.
3. Root operation Transfusion
Putting in blood or blood products
5. Approach Percutaneous
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
6. Device / Substance / Technology Etuvetidigene Autotemcel
For example
- WASKYRA(tm)
Codes in the same group
| Code | Description | Status |
|---|---|---|
| XW13325 | Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5 | Valid |
| XW1337A | Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10 | Valid |
| XW133B8 | Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 | Valid |
| XW133C8 | Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 | Valid |
| XW133D7 | Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 | Retired |
| XW133E7 | Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 | Valid |
| XW133F8 | Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 | Retired |
| XW133G8 | Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 | Valid |
| XW133H9 | Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9 | Valid |
| XW133J8 | Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 | Valid |
| XW133SB | Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11 | Valid |
| XW133YB | Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11 | Valid |